Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2

24 Sept 2008

Abstract excerpt

The clinical features of myotonic dystrophy type 1 (DM1) and type 2 (DM2) may present striking similarity, whereas, in some cases, the DM2 phenotype may be so mild that the diagnosis may be missed. Therefore, the identification of disease-specific histopathological patterns for DM1 and DM2 may help clinicians to correctly address genetic studies. We performed a comparative morphological and morphometric analysis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Muscle Physiology and Disorders
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18816606
DOI: 10.1002/mus.21122

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2PMID 18816606Read ↗

Type 2 Myotonic Dystrophy Can Be Predicted by the Combination of Type 2 Muscle Fiber Central Nucleation and Scattered AtrophySemantic proximity Read ↗

DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathySemantic proximity Read ↗

Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.Semantic proximity Read ↗

Imaging-based evaluation of pathogenicity by novel <i>DNM2 variants</i> associated with centronuclear myopathySemantic proximity Read ↗

A dog model for centronuclear myopathy carrying the most common DNM2 mutation.Semantic proximity Read ↗

Centronuclear myopathies: a widening concept.Semantic proximity Read ↗

Loss of Sarcomeric Scaffolding as a Common Baseline Histopathologic Lesion in Titin-Related MyopathiesSemantic proximity Read ↗

Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.Semantic proximity Read ↗

Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.Semantic proximity Read ↗

Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy.Semantic proximity Read ↗

Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.Semantic proximity Read ↗

PCM1 labeling reveals myonuclear and nuclear dynamics in skeletal muscle across speciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.